A new market access whitepaper

 

Preparing for the ICER assessment process:
key recommendations for manufacturers
 

New whitepaper
New whitepaper

Dear Colleague,

This new market access whitepaper explains how pharmaceutical and medical device manufacturers can prepare for the ICER assessment process.

Be among the first to read: 

 

  • 6 recommendations that will help you ensure your organization has a robust ICER strategy in place.
     
  • Why it is important to engage with ICER throughout the review process to drive the best possible outcomes.
     
  • How engagement in the ICER process helps prepare manufacturers to address cost-effectiveness concerns and discussions.
 


Please do share this email with your colleagues.

Kind regards,
PRMA Consulting

 


Navigating the
updated 2020 
ICER
value assessment framework

  

On-demand webinar
Watch now


ICER 2020 value assessment framework: 7 updates
  

Market access update
Market access update


PRMA Healthcheck® for assets in early stages of clinical development
  

New webinar
New webinar

Linea House

Harvest Crescent

Fleet, Hampshire

GU51 2UZ, UK

 

 

UK (HQ) +44 (0)1252 786284

US +1 (415) 655 6798

Company number: 05893400

 

 

 

Follow us

         

 

This email was sent on behalf of the sponsor by HealthEconomics.Com, 1327 Walnut, Jacksonville, FL, 32206.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here, or send your request in writing to the address above.
Read more about our privacy policy here. You may also request a copy in writing using the address above.

To ensure you continue to receive emails from HealthEconomics.Com, please click here.